Clinical Trial Update: Non-interference Study of MR and Yellow Fever Vaccines Among Bangladeshi Infants Aged 9-12 Months [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating non-interference between the Measles-Rubella (MR) vaccine and the Yellow Fever vaccine in Bangladeshi infants aged 9-12 m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Measles
• Rubella
• Yellow Fever

Drugs mentioned

• Measles-Rubella vaccine (MR) (Measles-Rubella vaccine)
• Yellow fever vaccine (live attenuated yellow fever vaccine)

Snippet

Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh | Conditions: Measles, Rubella | Phase 3 | Status: NOT_YET_RECRUITING